Research output per year
Research output per year
- 24 results
Search results
-
2024
Feasibility of 177Lu activity quantification using a small portable CZT-based gamma-camera
Roth, D., Larsson, E., Strand, J., Ljungberg, M. & Sjögreen Gleisner, K., 2024 Dec, In: EJNMMI Physics. 11, 1, 2.Research output: Contribution to journal › Article › peer-review
Open Access -
Intratumoral Distribution of [177Lu]Lu-PSMA-617 Over Time and in Relation to Diagnostic Tracers in Animal Models of Prostate Cancer
Örbom, A., Strand, J., Altai, M., Zedan, W., Kristiansson, A., Ceder, J. & Timmermand, O. V., 2024 Nov 27, (E-pub ahead of print) In: Cancer Biotherapy and Radiopharmaceuticals.Research output: Contribution to journal › Article › peer-review
-
Evaluation of superficial xenograft volume estimation by ultrasound and caliper against MRI in a longitudinal pre-clinical radiotherapeutic setting
Roth, D., Safi, M., Vilhelmsson Timmermand, O., Sereti, E., Molendowska, M., Gottschalk, M., Bjartell, A., Ceberg, C., Szczepankiewicz, F. & Strand, J., 2024 Jul 25, In: PLoS ONE. 19, 7, e0307558.Research output: Contribution to journal › Article › peer-review
Open Access -
2023
Co-injection of anti-HER2 antibody Trastuzumab does not increase efficacy of [177Lu]Lu-PSMA-617 therapy in an animal model of prostate cancer
Abouzayed, A., Zedan, W., Altai, M., Strand, J. & Örbom, A., 2023 Jun 30, In: American journal of nuclear medicine and molecular imaging. 13, 3, p. 107-117Research output: Contribution to journal › Article › peer-review
Open Access -
Evaluation of enhanced permeability effect and different linear energy transfer of radionuclides in a prostate cancer xenograft model
Vilhelmsson Timmermand, O., Safi, M., Holmqvist, B. & Strand, J., 2023, In: American journal of nuclear medicine and molecular imaging. 13, 4, p. 147-155Research output: Contribution to journal › Article › peer-review
Open Access -
2022
Hematological Toxicity in Mice after High Activity Injections of 177Lu-PSMA-617
Kristiansson, A., Vilhelmsson Timmermand, O., Altai, M., Strand, J., Strand, S.-E., Åkerström, B. & Örbom, A., 2022, In: Pharmaceutics. 14, 4, 731.Research output: Contribution to journal › Article › peer-review
Open Access -
2021
A conjugation strategy to modulate antigen binding and FcRn interaction leads to improved tumor targeting and radioimmunotherapy efficacy with an antibody targeting prostate-specific antigen
Vilhelmsson Timmermand, O., Örbom, A., Altai, M., Zedan, W., Holmqvist, B., Safi, M., Tran, T. A., Strand, S. E. & Strand, J., 2021 Jul 2, In: Cancers. 13, 14, 3469.Research output: Contribution to journal › Article › peer-review
Open Access -
PSA-Targeted Alpha-, Beta-, and Positron-emitting immunotheranostics in murine prostate cancer models and nonhuman primates
Veach, D. R., Storey, C. M., Lückerath, K., Braun, K., Von Bodman, C., Lamminmäki, U., Kalidindi, T., Strand, S. E., Strand, J., Altai, M., Damoiseaux, R., Zanzonico, P., Benabdallah, N., Pankov, D., Scher, H. I., Scardino, P., Larson, S. M., Lilja, H., McDevitt, M. R. & Thorek, D. L. J. & 1 others, , 2021 Apr, In: Clinical Cancer Research. 27, 7, p. 2050-2060 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
177Lu-PSMA-617 Therapy in Mice, with or without the Antioxidant α1-Microglobulin (A1M), Including Kidney Damage Assessment Using 99mTc-MAG3 Imaging
Kristiansson, A., Örbom, A., Ahlstedt, J., Karlsson, H., Zedan, W., Gram, M., Åkerström, B., Strand, S.-E., Altai, M., Strand, J. & Vilhelmsson Timmermand, O., 2021 Feb 10, In: Biomolecules. 11, 2, 263.Research output: Contribution to journal › Article › peer-review
Open Access -
Humanization, radiolabeling and biodistribution studies of an igg1-type antibody targeting uncomplexed psa for theranostic applications
Strand, J., Sjöström, K., Lamminmaki, U. J., Timmermand, O. V., Strand, S. E. & Tran, T. A., 2021, In: Pharmaceuticals. 14, 12, 1251.Research output: Contribution to journal › Article › peer-review
Open Access -
2016
Increasing the Net Negative Charge by Replacement of DOTA Chelator with DOTAGA Improves the Biodistribution of Radiolabeled Second-Generation Synthetic Affibody Molecules
Westerlund, K., Honarvar, H., Norrström, E., Strand, J., Mitran, B., Orlova, A., Eriksson Karlström, A. & Tolmachev, V., 2016 May 2, In: Molecular Pharmaceutics. 13, 5, p. 1668-1678Research output: Contribution to journal › Article › peer-review
-
2015
Site-Specific Radioiodination of HER2-Targeting Affibody Molecules using 4-Iodophenethylmaleimide Decreases Renal Uptake of Radioactivity
Strand, J., Nordeman, P., Honarvar, H., Altai, M., Orlova, A., Larhed, M. & Tolmachev, V., 2015, In: ChemistryOpen. 4, 2, p. 174-182Research output: Contribution to journal › Article › peer-review
Open Access -
2014
Selection of an optimal cysteine-containing peptide-based chelator for labeling of affibody molecules with (188)Re
Altai, M., Honarvar, H., Wållberg, H., Strand, J., Varasteh, Z., Rosestedt, M., Orlova, A., Dunås, F., Sandström, M., Löfblom, J., Tolmachev, V. & Ståhl, S., 2014 Nov 24, In: European Journal of Medicinal Chemistry. 87, p. 519-28Research output: Contribution to journal › Article › peer-review
Open Access -
Gallium-68-labeled affibody molecule for PET imaging of PDGFRβ expression in vivo
Strand, J., Varasteh, Z., Eriksson, O., Abrahmsen, L., Orlova, A. & Tolmachev, V., 2014 Nov 3, In: Molecular Pharmaceutics. 11, 11, p. 3957-64 8 p.Research output: Contribution to journal › Article › peer-review
-
188Re-ZHER2:V2, a promising affibody-based targeting agent against HER2-expressing tumors: preclinical assessment
Altai, M., Wållberg, H., Honarvar, H., Strand, J., Orlova, A., Varasteh, Z., Sandström, M., Löfblom, J., Larsson, E., Strand, S.-E., Lubberink, M., Ståhl, S. & Tolmachev, V., 2014 Nov, In: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 55, 11, p. 1842-8Research output: Contribution to journal › Article › peer-review
Open Access -
Imaging of HER3-expressing xenografts in mice using a (99m)Tc(CO) 3-HEHEHE-Z HER3:08699 affibody molecule
Orlova, A., Malm, M., Rosestedt, M., Varasteh, Z., Andersson, K., Selvaraju, R. K., Altai, M., Honarvar, H., Strand, J., Ståhl, S., Tolmachev, V. & Löfblom, J., 2014 Jul, In: European Journal of Nuclear Medicine and Molecular Imaging. 41, 7, p. 1450-9Research output: Contribution to journal › Article › peer-review
-
Incorporation of a triglutamyl spacer improves the biodistribution of synthetic affibody molecules radiofluorinated at the N-terminus via oxime formation with (18)F-4-fluorobenzaldehyde
Rosik, D., Thibblin, A., Antoni, G., Honarvar, H., Strand, J., Selvaraju, R. K., Altai, M., Orlova, A., Eriksson Karlström, A. & Tolmachev, V., 2014 Jan 15, In: Bioconjugate Chemistry. 25, 1, p. 82-92 11 p.Research output: Contribution to journal › Article › peer-review
-
Position for site-specific attachment of a DOTA chelator to synthetic affibody molecules has a different influence on the targeting properties of 68Ga- compared to 111in-labeled conjugates
Honarvar, H., Strand, J., Perols, A., Orlova, A., Selvaraju, R. K., Eriksson Karlström, A. & Tolmachev, V., 2014, In: Molecular Imaging. 13Research output: Contribution to journal › Article › peer-review
Open Access -
2013
HAHAHA, HEHEHE, HIHIHI, or HKHKHK: influence of position and composition of histidine containing tags on biodistribution of [(99m)Tc(CO)3](+)-labeled affibody molecules
Hofström, C., Altai, M., Honarvar, H., Strand, J., Malmberg, J., Hosseinimehr, S. J., Orlova, A., Gräslund, T. & Tolmachev, V., 2013 Jun 27, In: Journal of Medicinal Chemistry. 56, 12, p. 4966-74Research output: Contribution to journal › Article › peer-review
-
Influence of nuclides and chelators on imaging using affibody molecules: comparative evaluation of recombinant affibody molecules site-specifically labeled with ⁶⁸Ga and ¹¹¹In via maleimido derivatives of DOTA and NODAGA
Altai, M., Strand, J., Rosik, D., Selvaraju, R. K., Eriksson Karlström, A., Orlova, A. & Tolmachev, V., 2013 Jun 19, In: Bioconjugate Chemistry. 24, 6, p. 1102-9Research output: Contribution to journal › Article › peer-review
-
[99mTc(CO)3]+-(HE)3-ZIGF1R:4551, a new Affibody conjugate for visualization of insulin-like growth factor-1 receptor expression in malignant tumours
Orlova, A., Hofström, C., Strand, J., Varasteh, Z., Sandstrom, M., Andersson, K., Tolmachev, V. & Gräslund, T., 2013 Feb, In: European Journal of Nuclear Medicine and Molecular Imaging. 40, 3, p. 439-49Research output: Contribution to journal › Article › peer-review
-
Influence of macrocyclic chelators on the targeting properties of (68)Ga-labeled synthetic affibody molecules: comparison with (111)In-labeled counterparts
Strand, J., Honarvar, H., Perols, A., Orlova, A., Selvaraju, R. K., Karlström, A. E. & Tolmachev, V., 2013, In: PLoS ONE. 8, 8, 10 p., e70028.Research output: Contribution to journal › Article › peer-review
Open Access -
2012
Influence of DOTA chelator position on biodistribution and targeting properties of (111)In-labeled synthetic anti-HER2 affibody molecules
Perols, A., Honarvar, H., Strand, J., Selvaraju, R., Orlova, A., Karlström, A. E. & Tolmachev, V., 2012 Aug 15, In: Bioconjugate Chemistry. 23, 8, p. 1661-70 10 p.Research output: Contribution to journal › Article › peer-review
-
Targeting Free Prostate-Specific Antigen for In Vivo Imaging of Prostate Cancer Using a Monoclonal Antibody Specific for Unique Epitopes Accessible on Free Prostate-Specific Antigen Alone.
Evans Axelsson, S., Ulmert, D., Örbom, A., Peterson, P., Nilsson, O., Wennerberg, J., Strand, J., Wingårdh, K., Olsson, T., Hagman, Z., Tolmachev, V., Bjartell, A., Lilja, H. & Strand, S.-E., 2012, In: Cancer Biotherapy & Radiopharmaceuticals. 27, 4, p. 243-251Research output: Contribution to journal › Article › peer-review
196 Downloads (Pure)